These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7578407)

  • 21. Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer.
    O'Keefe DS; Uchida A; Bacich DJ; Watt FB; Martorana A; Molloy PL; Heston WD
    Prostate; 2000 Oct; 45(2):149-57. PubMed ID: 11027414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo suicide gene therapy model using a newly discovered prostate-specific membrane antigen promoter/enhancer: a potential alternative approach to androgen deprivation therapy.
    Uchida A; O'Keefe DS; Bacich DJ; Molloy PL; Heston WD
    Urology; 2001 Aug; 58(2 Suppl 1):132-9. PubMed ID: 11502468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo footprint analysis of the promoter of carcinoembryonic antigen in colon carcinoma cells: effects of interferon gamma treatment.
    Chen CJ; Li LJ; Maruya A; Shively JE
    Cancer Res; 1995 Sep; 55(17):3873-82. PubMed ID: 7641207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Epstein-Barr virus nuclear antigen-1 in targeted therapy of EBV-associated neoplasia.
    Judde JG; Spangler G; Magrath I; Bhatia K
    Hum Gene Ther; 1996 Mar; 7(5):647-53. PubMed ID: 8845390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Carcinoembryonic Antigen Gene Promoter in Colorectal Carcinoma-specific Suicidal Gene Therapy.
    Jiang Q; Ge K; Xu DH; Sun LY; Zheng ZC; Liu XY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 1998; 30(1):1-8. PubMed ID: 12174289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue specific cytotoxicity of colon cancer cells mediated by nanoparticle-delivered suicide gene in vitro and in vivo.
    Zhang G; Liu T; Chen YH; Chen Y; Xu M; Peng J; Yu S; Yuan J; Zhang X
    Clin Cancer Res; 2009 Jan; 15(1):201-7. PubMed ID: 19118047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human nerve growth factor receptor and cytosine deaminase fusion genes.
    Lewis VA; Basso L; Blake N; Salo J; Lund TC; McIvor RS; Orchard PJ
    Hum Gene Ther; 2003 Jul; 14(10):1009-16. PubMed ID: 12869218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-specific chemo-radio-gene therapy for colorectal cancer cells using adenovirus vector expressing the cytosine deaminase gene.
    Ueno M; Koyama F; Yamada Y; Fujimoto H; Takayama T; Kamada K; Naito A; Hirao S; Mukogawa T; Hamada H; Nakajima Y
    Anticancer Res; 2001; 21(4A):2601-8. PubMed ID: 11724328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic intra-arterial delivery of a retroviral vector expressing the cytosine deaminase gene, controlled by the CEA promoter and intraperitoneal treatment with 5-fluorocytosine suppresses growth of colorectal liver metastases.
    Humphreys MJ; Ghaneh P; Greenhalf W; Campbell F; Clayton TM; Everett P; Huber BE; Richards CA; Ford MJ; Neoptolemos JP
    Gene Ther; 2001 Aug; 8(16):1241-7. PubMed ID: 11509957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase.
    Huber BE; Austin EA; Good SS; Knick VC; Tibbels S; Richards CA
    Cancer Res; 1993 Oct; 53(19):4619-26. PubMed ID: 8402637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.
    Peng XY; Won JH; Rutherford T; Fujii T; Zelterman D; Pizzorno G; Sapi E; Leavitt J; Kacinski B; Crystal R; Schwartz P; Deisseroth A
    Cancer Res; 2001 Jun; 61(11):4405-13. PubMed ID: 11389068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene.
    Kanai F; Lan KH; Shiratori Y; Tanaka T; Ohashi M; Okudaira T; Yoshida Y; Wakimoto H; Hamada H; Nakabayashi H; Tamaoki T; Omata M
    Cancer Res; 1997 Feb; 57(3):461-5. PubMed ID: 9012474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.
    Hanna NN; Mauceri HJ; Wayne JD; Hallahan DE; Kufe DW; Weichselbaum RR
    Cancer Res; 1997 Oct; 57(19):4205-9. PubMed ID: 9331076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system.
    Koch PE; Guo ZS; Kagawa S; Gu J; Roth JA; Fang B
    Mol Ther; 2001 Mar; 3(3):278-83. PubMed ID: 11273768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer.
    Cao X; Huang X; Ju DW; Zhang W; Hamada H; Wang J
    Cancer Gene Ther; 2000 Feb; 7(2):177-86. PubMed ID: 10770625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A safe, effective in vivo gene therapy for melanoma using tyrosinase promoter-driven cytosine deaminase gene.
    Cao G; Zhang X; He X; Chen Q; Qi Z
    In Vivo; 1999; 13(2):181-7. PubMed ID: 10363176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter analysis of RPE65, the gene encoding a 61-kDa retinal pigment epithelium-specific protein.
    Nicoletti A; Kawase K; Thompson DA
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):637-44. PubMed ID: 9501877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type-specific expression.
    Schrewe H; Thompson J; Bona M; Hefta LJ; Maruya A; Hassauer M; Shively JE; von Kleist S; Zimmermann W
    Mol Cell Biol; 1990 Jun; 10(6):2738-48. PubMed ID: 2342461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line.
    Trinh QT; Austin EA; Murray DM; Knick VC; Huber BE
    Cancer Res; 1995 Nov; 55(21):4808-12. PubMed ID: 7585511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 3' untranslated region of the carcinoembryonic antigen gene plays a minimal role in the regulation of gene expression.
    Bordonaro M; Augenlicht L
    Cell Growth Differ; 1997 Mar; 8(3):353-60. PubMed ID: 9056678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.